GLIN News

Quality Newsletter - Quarter 1 2023

Quality Newsletter - Quarter 1 2023

March 1, 2023

GLIN PharmacyFactor - Antidepressant Medication Management and Quality Update, Part I, February 2023

GLIN PharmacyFactor - Antidepressant Medication Management and Quality Update, Part I, February 2023

February 23, 2023

GLIN PharmacyFactor - COPD Treatment Guideline and Quality Update, January 2023

GLIN PharmacyFactor - COPD Treatment Guideline and Quality Update, January 2023

January 26, 2023

GLIN PharmacyFactor - Myths Regarding Diabetes, December 2022

GLIN PharmacyFactor - Myths Regarding Diabetes, December 2022

December 13, 2022

GLIN PharmacyFactor - Osteoporosis Treatment Guideline and Quality Update, November 2022

GLIN PharmacyFactor - Osteoporosis Treatment Guideline and Quality Update, November 2022

November 10, 2022

Quality Newsletter - Quarter 4 2022

Quality Newsletter - Quarter 4 2022

October 19, 2022

GLIN PharmacyFactor - Asthma Treatment Guideline and Quality Update, October 2022

GLIN PharmacyFactor - Asthma Treatment Guideline and Quality Update, October 2022

October 10, 2022

GLIN PharmacyFactor - Hypertension Guideline and Quality Update, August 2022

GLIN PharmacyFactor - Hypertension Guideline and Quality Update, August 2022

August 4, 2022

Quality Newsletter - Quarter 3 2022

Quality Newsletter - Quarter 3 2022

July 13, 2022

For additional information please call 1-844-769-5879 or email GLINinfo@glin.com

For compliance and security-related concerns, please contact compliance@glin.com or call 716-512-7638